XML 118 R26.htm IDEA: XBRL DOCUMENT v3.22.4
Collaborations (Tables)
12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Change in Accounts Receivable, Contract Asset and Liabilities

The following table presents the changes in accounts receivable, contract assets and liabilities for the year ended December 31, 2022 (in thousands)

 

 

 

Balance at
December 31, 2021

 

 

Additions

 

 

Deductions

 

 

Balance at
December 31, 2022

 

Accounts receivable and contract assets:

 

 

 

 

 

 

 

 

 

 

 

 

Billed receivables – Sanofi

 

$

 

 

$

6,650

 

 

$

(6,650

)

 

$

 

Unbilled receivables – Sanofi

 

 

135

 

 

 

9,052

 

 

 

(6,650

)

 

 

2,537

 

Total accounts receivable and contract assets

 

$

135

 

 

$

15,702

 

 

$

(13,300

)

 

$

2,537

 

Contract Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Deferred Revenue – Vertex

 

$

19,212

 

 

$

 

 

$

(10,813

)

 

$

8,399

 

Deferred Revenue – Sanofi

 

 

81,822

 

 

 

9,052

 

 

 

(36,013

)

 

 

54,861

 

Total contract liabilities

 

$

101,034

 

 

$

9,052

 

 

$

(46,826

)

 

$

63,260